Thomas MR - Search Results

1

FTIR and resonance Raman studies of nitric oxide binding to H93G cavity mutants of myoglobin.

Thomas MR, Brown D, Franzen S, Boxer SG. Thomas MR, et al. Biochemistry. 2001 Dec 11;40(49):15047-56. doi: 10.1021/bi011440l. Biochemistry. 2001. PMID: 11732927

2

Proximal ligand motions in H93G myoglobin.

Franzen S, Peterson ES, Brown D, Friedman JM, Thomas MR, Boxer SG. Franzen S, et al. Among authors: thomas mr. Eur J Biochem. 2002 Oct;269(19):4879-86. doi: 10.1046/j.1432-1033.2002.03193.x. Eur J Biochem. 2002. PMID: 12354119 Free article.

3

Assignment of the heme axial ligand(s) for the ferric myoglobin (H93G) and heme oxygenase (H25A) cavity mutants as oxygen donors using magnetic circular dichroism.

Pond AE, Roach MP, Sono M, Rux AH, Franzen S, Hu R, Thomas MR, Wilks A, Dou Y, Ikeda-Saito M, Ortiz de Montellano PR, Woodruff WH, Boxer SG, Dawson JH. Pond AE, et al. Among authors: thomas mr. Biochemistry. 1999 Jun 8;38(23):7601-8. doi: 10.1021/bi9825448. Biochemistry. 1999. PMID: 10360958

4

The H93G myoglobin cavity mutant as a versatile template for modeling heme proteins: ferrous, ferric, and ferryl mixed-ligand complexes with imidazole in the cavity.

Pond AE, Roach MP, Thomas MR, Boxer SG, Dawson JH. Pond AE, et al. Among authors: thomas mr. Inorg Chem. 2000 Dec 25;39(26):6061-6. doi: 10.1021/ic0007198. Inorg Chem. 2000. PMID: 11151505

5

A photolysis-triggered heme ligand switch in H93G myoglobin.

Franzen S, Bailey J, Dyer RB, Woodruff WH, Hu RB, Thomas MR, Boxer SG. Franzen S, et al. Among authors: thomas mr. Biochemistry. 2001 May 1;40(17):5299-305. doi: 10.1021/bi0023403. Biochemistry. 2001. PMID: 11318654

6

19F NMR of trifluoroacetyl-labeled cysteine mutants of myoglobin: structural probes of nitric oxide bound to the H93G cavity mutant.

Thomas MR, Boxer SG. Thomas MR, et al. Biochemistry. 2001 Jul 24;40(29):8588-96. doi: 10.1021/bi0101087. Biochemistry. 2001. PMID: 11456499

7

Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction.

Khattak S, Townend JN, Thomas MR. Khattak S, et al. Among authors: thomas mr. Front Mol Biosci. 2024 Mar 13;11:1287553. doi: 10.3389/fmolb.2024.1287553. eCollection 2024. Front Mol Biosci. 2024. PMID: 38545417 Free PMC article. Review.

8

GPVI as an effective antithrombotic target.

Slater A, Khattak S, Thomas MR. Slater A, et al. Among authors: thomas mr. Eur Heart J Cardiovasc Pharmacother. 2024 Mar 7:pvae018. doi: 10.1093/ehjcvp/pvae018. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38453424

9

Cultivating Cultural Humility to Address the Healthcare Burnout Epidemic-Why It Matters.

Elbanna MF, Thomas MR, Patel PR, McHenry MS. Elbanna MF, et al. Among authors: thomas mr. Glob Adv Integr Med Health. 2023 May 11;12:27536130231162350. doi: 10.1177/27536130231162350. eCollection 2023 Jan-Dec. Glob Adv Integr Med Health. 2023. PMID: 38370146 Free PMC article.

10

ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura.

Underwood MI, Thomas MR, Scully MA, Crawley JTB. Underwood MI, et al. Among authors: thomas mr. J Thromb Haemost. 2024 Apr;22(4):1069-1079. doi: 10.1016/j.jtha.2023.12.028. Epub 2023 Dec 30. J Thromb Haemost. 2024. PMID: 38160729 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page